Antitumor Activities and Pharmacodynamic Biomarkers of a Novel and Orally Available Small Molecule IAP Antagonist

被引：0
|
作者：
Sumi, H.
Yabuki, M.
Iwai, K.
Hashimoto, K.
Kosugi, Y.
Yoshimatsu, M.
Ishikawa, T.
Yoshida, S.
机构：
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)71871-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
73
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [41] Discovery and characterization of a high orally available small molecule inhibitor of KRASG12D
    Zhang, Y.
    Feng, Z.
    Huang, X.
    Sun, M.
    Yang, F.
    Yu, H.
    Chen, Z.
    Ying, H.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S17 - S17
  • [42] Identification of novel and potent small-molecule inhibitors of tubulin with antitumor activities by virtual screening and biological evaluations
    Liu, Guangpu
    Jiao, Yang
    Huang, Chunxi
    Chang, Ping
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2019, 33 (07) : 659 - 664
  • [43] Orally available stilbene derivatives as potent HDAC inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts
    Kachhadia, Virendra
    Rajagopal, Sridharan
    Ponpandian, Thanasekaran
    Vignesh, Radhakrishnan
    Anandhan, Karnambaram
    Prabhu, Daivasigamani
    Rajendran, Praveen
    Nidhyanandan, Saranya
    Roy, Anshu Mittal
    Ahamed, Fakrudeen Ali
    Surendran, Narayanan
    Rajagopal, Sriram
    Narayanan, Shridhar
    Gopalan, Balasubramanian
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 108 : 274 - 286
  • [44] An orally available small-molecule inhibitor of c-met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms
    Zou, Helen Y.
    Li, Qiuhua
    Lee, Joseph H.
    Arango, Maria E.
    McDonnell, Scott R.
    Yamazaki, Shinji
    Koudriakova, Tatiana B.
    Alton, Gordon
    Cui, Jingrong J.
    Kung, Pei-Pei
    Nambu, Mitchell D.
    Los, Gerrit
    Bender, Steven L.
    Mroczkowski, Barbara
    Christensen, James G.
    CANCER RESEARCH, 2007, 67 (09) : 4408 - 4417
  • [45] Toxicity Profile of Small-Molecule IAP Antagonist GDC-0152 Is Linked to TNF-α Pharmacology
    Erickson, Rebecca I.
    Tarrant, Jacqueline
    Cain, Gary
    Lewin-Koth, Sock-Cheng
    Dybdal, Noel
    Wong, Harvey
    Blackwood, Elizabeth
    West, Kristina
    Steigerwalt, Ronald
    Mamounas, Michael
    Flygare, John A.
    Amemiya, Kenjie
    Dambach, Donna
    Fairbrother, Wayne J.
    Diaz, Dolores
    TOXICOLOGICAL SCIENCES, 2013, 131 (01) : 247 - 258
  • [46] Biological characterization of a novel, orally active small molecule gonadotropin-releasing hormone (GnRH) antagonist using castrated and intact rats
    Anderes, KL
    Luthin, DR
    Castillo, R
    Kraynov, EA
    Castro, M
    Hood, KN
    Gregory, ML
    Pathak, VP
    Christie, LC
    Paderes, G
    Vazir, H
    Ye, Q
    Anderson, MB
    May, JM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (02): : 688 - 695
  • [47] Development of novel, potent orally available Wee1 inhibitors with robust antitumor efficacy in vivo
    Gavory, Gerald
    O'Dowd, Colin
    Rozycka, Ewelina
    Boyd, Caroline
    Gorges, Beronia
    McLean, Estelle
    Rountree, Shane
    Sheperd, Steven
    Burton, Stephanie
    McFarland, Mary
    Janssen, Dominic
    Treder, Adam
    Wilkinson, Andy
    Burkamp, Frank
    Harrison, Tim
    MOLECULAR CANCER RESEARCH, 2017, 15
  • [48] The discovery of a novel orally available CCR5 antagonist, as a therapeutic for HIV-1 infection
    Nogi, Rena Nishizawa
    Nishiyama, Toshihiko
    Hisaichi, Katsuya
    Minamoto, Chiaki
    Matsunaga, Naoki
    Hirai, Keisuke
    Habashita, Hiromu
    Takaoka, Yoshikazu
    Toda, Masaaki
    Takahashi, Eiji
    Imawaka, Haruo
    Sagawa, Kenji
    Shibayama, Shiro
    Fukushima, Daikichi
    Maeda, Kenji
    Mitsuya, Hiroaki
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [49] Clinical Pharmacokinetic and Pharmacodynamic Profile of Lenvatinib, an Orally Active, Small-Molecule, Multitargeted Tyrosine Kinase Inhibitor
    Hussein, Ziad
    Mizuo, Hitoshi
    Hayato, Seiichi
    Namiki, Masayuki
    Shumaker, Robert
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (06) : 903 - 914
  • [50] Pharmacological characterization of a novel, orally available GluN2B antagonist JNJ-63612445
    Balana, Bartosz
    Schoellerman, Jeffrey
    Lord, Brian
    Wyatt, Ryan
    Matta, Jose
    Neff, Robert
    Welty, Natalie
    Bhattacharya, Anindya
    Bonaventure, Pascal
    Lovenberg, Tim
    Letavic, Michael
    FASEB JOURNAL, 2020, 34
12345